Combinational Therapy in Triple Negative Breast Cancer

preview-18
  • Combinational Therapy in Triple Negative Breast Cancer Book Detail

  • Author : Manzoor Ahmad Mir
  • Release Date : 2022-04-28
  • Publisher : Academic Press
  • Genre : Science
  • Pages : 262
  • ISBN 13 : 0323961371
  • File Size : 86,86 MB

Combinational Therapy in Triple Negative Breast Cancer by Manzoor Ahmad Mir PDF Summary

Book Description: Combinational Therapy in Triple Negative Breast Cancer discusses TNBC at the molecular level from a holistic approach, focusing on combinational strategies targeting various pathways involved in this specific cancer type. Using a monotherapy for the treatment of cancer, especially high-grade tumors like TNBC, is mostly worthless due to the inherent genetic instability of tumor cells to develop intrinsic and acquired resistance. Combination therapy presents more, or at least the same, effectiveness with lower doses of every single agent and decreases the likelihood of chemoresistance, making it essential to understand for multiple therapy options. The book is a valuable resource for cancer researchers, oncologists, graduate students and members of the biomedical field who are interested in the potential of combinational therapies to treat triple negative breast cancer. Presents up-to-date and cutting-edge knowledge of Triple negative breast cancer (TNBC) biology, clinical aspects and treatment options Discusses novel targets and pathways involved in TNBC Provides insights and approaches for future research on TNBC

Disclaimer: www.yourbookbest.com does not own Combinational Therapy in Triple Negative Breast Cancer books pdf, neither created or scanned. We just provide the link that is already available on the internet, public domain and in Google Drive. If any way it violates the law or has any issues, then kindly mail us via contact us page to request the removal of the link.

Metronomic Chemotherapy

Metronomic Chemotherapy

File Size : 28,28 MB
Total View : 1925 Views
DOWNLOAD

This book analyzes all aspects of metronomic chemotherapy, a new approach involving low-dose, long-term, and frequently administered therapy that has preclinica